Charles Hummer, MD
Orthopaedic Surgery · Media, PANPI 1912953670
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.2%), consulting fees and education — rather than concentrated in one kind of arrangement. Sanofi-aventis U.S. LLC accounts for 78.8% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2020 at $10,258 and has fallen 98.0% since, to $208 in 2025.
Across 92 payments — averaging $327.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$24K
- Arthrex$3K
- Liberty Surgical Inc.$2K
- Stryker$392
- Zimmer Biomet$355
- Pacira Therapeutics, Inc.$309
- plus $871 from 16 others
Across 1 payment — averaging $1250.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi-aventis U.S. LLC$1K
What the payments were for
- Consulting fees$7,73026%
- Speaking & faculty fees$16,02953%
- Travel & lodging$1,0503%
- Food & beverage$2,0207%
- Education$3,32411%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 14 | $23,755 |
| Arthrex | 11 | $2,727 |
| Liberty Surgical Inc. | 2 | $1,744 |
| Stryker | 7 | $392 |
| Zimmer Biomet | 4 | $355 |
| Pacira Therapeutics, Inc. | 16 | $309 |
| Johnson & Johnson | 15 | $254 |
| Eclipse Technology Solutions Inc. | 5 | $210 |
| Bioventus LLC | 3 | $76 |
| Dynasplint Systems Inc. | 2 | $70 |
| Medical Device Business Services, Inc. | 1 | $49 |
| Heraeus Medical, LLC. | 2 | $31 |
| Ferring Pharmaceuticals Inc. | 1 | $25 |
| Solventum Corporation | 1 | $24 |
| Avanos Medical | 1 | $24 |
| KCI USA, Inc. | 1 | $23 |
| Fidia Pharma USA Inc. | 1 | $20 |
| Smith+Nephew | 1 | $16 |
| Amgen | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| ERMI LLC | 1 | $12 |
| DJO, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNVISC$19,949
- NO PRODUCT DISCUSSED$3,760
- Juggerknotless Soft Anchor$154
- MAKO$137
- EBI Bone Healing System$126
How this compares
$30,153 in reported general payments places this provider in the 85th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 67 | $184 |
| Gabapentin | 14 | $116 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $88 |
| Oxycodone Hcl | 16 | $72 |
| Tramadol Hcl | 19 | $30 |
| Amoxicillin | 25 | $26 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Media
- William HozackBensalem$10.6M
- Jess LonnerBryn Mawr$7.8M
- Gerald WilliamsBryn Mawr$6.8M
- Mark LazarusBensalem$6.4M
- John FenlinPhiladelphia$5.9M
- Peter SharkeyKing Of Prussia$5.7M
- Alexander VaccaroPhiladelphia$4.5M
- Selene ParekhBensalem$4.5M
- Joseph AbboudPhiladelphia$3.9M
- Jonathan GarinoMalvern$3.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.